Planned phase I trial of OVI 117 as a treatment for solid tumours.
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2012
At a glance
- Drugs OVI 117 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 10 Jul 2012 The US FDA has granted approval to initiate this trial, according to an OncoVista Innovative Technologies media release.
- 15 Jul 2011 Planned initiation date changed to 1 Oct 2011.
- 15 Jul 2011 Status changed from not stated to planning.